Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
IMMUNOLOGY: B Cell Receptor Rehabilitation--Pausing to Reflect
Leslie B. King and John G. Monroe
Immunologists have long been fascinated by how the immune system gets rid of immature B cells carrying antibody against self antigens before they can do any real damage. Clonal deletion (death) and clonal anergy (disability) are two mechanisms for inducing tolerance to self antigens in order to avoid autoimmunity. Recently, a third more parsimonious mechanism, receptor editing, has been described. However, it has been difficult to reconcile how cell death and receptor editing can coexist as distinct tolerance mechanisms. Even more contentious has been defining the stage in B cell development where these processes take place. Now, according to King and Monroe in their Perspective, recent work by Casellas et al. may have shed some light on these issues. Self-reactive B cells pause during their development in the bone marrow and attempt to remove the offending antibodies without destroying or inactivating the developing B cells that bear them. Those that fail to accomplish this are likely doomed to die.
The authors are in the Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. E-mail: monroej{at}mail.med.upenn.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Rafael Casellas, Tien-An Yang Shih, Markus Kleinewietfeld, Jasna Rakonjac, David Nemazee, Klaus Rajewsky, and Michel C. Nussenzweig (23 February 2001) Science291 (5508), 1541.
[DOI: 10.1126/science.1056600] |Abstract »|Full Text »|PDF »|Supplemental Data »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Define CXCR4 Antigenic Heterogeneity.
C. Xu, J. Sui, H. Tao, Q. Zhu, and W. A. Marasco (2007)
J. Immunol.
179, 2408-2418
|Abstract »|Full Text »|PDF »
DNA Cleavage of a Cryptic Recombination Signal Sequence by RAG1 and RAG2: IMPLICATIONS FOR PARTIAL VH GENE REPLACEMENT.
N. S. Rahman, L. J. Godderz, S. J. Stray, J. D. Capra, and K. K. Rodgers (2006)
J. Biol. Chem.
281, 12370-12380
|Abstract »|Full Text »|PDF »
Visualization of the Genesis and Fate of Isotype-switched B Cells during a Primary Immune Response.
K. A. Pape, V. Kouskoff, D. Nemazee, H. L. Tang, J. G. Cyster, L. E. Tze, K. L. Hippen, T. W. Behrens, and M. K. Jenkins (2003)
J. Exp. Med.
197, 1677-1687
|Abstract »|Full Text »|PDF »
Human cord blood CD34+Pax-5+ B-cell progenitors: single-cell analyses of their gene expression profiles.
E. Sanz, M. Alvarez-Mon, C. Martinez-A, and A. de la Hera (2003)
Blood
101, 3424-3430
|Abstract »|Full Text »|PDF »
V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation.
Y.-H. Wang, Z. Zhang, P. D. Burrows, H. Kubagawa, S. L. Bridges Jr, H. W. Findley, and M. D. Cooper (2003)
Blood
101, 1030-1037
|Abstract »|Full Text »|PDF »
The Avian Chb6 Alloantigen Triggers Apoptosis in a Mammalian Cell Line.
